Comparison between Chemplast Sanmar IPO and Krsnaa Diagnostics IPO.
Chemplast Sanmar IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Krsnaa Diagnostics IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Chemplast Sanmar IPO is up to ₹3,850.00 Cr whereas the issue size of the Krsnaa Diagnostics IPO is up to ₹1,213.33 Cr. The final issue price of Chemplast Sanmar IPO is ₹541.00 per share and of Krsnaa Diagnostics IPO is ₹954.00 per share.
| Chemplast Sanmar IPO | Krsnaa Diagnostics IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹5 per share |
| Issue Price (Lower) | ₹530.00 per share | ₹933.00 per share |
| Issue Price (Upper) | ₹541.00 per share | ₹954.00 per share |
| Issue Price (Final) | ₹541.00 per share | ₹954.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹93.00 per share | |
| Market Lot Size | 27 shares | 15 shares |
| Fresh Issue Size | 2,40,29,574 shares | 42,06,085 shares |
| Fresh Issue Size (Amount) | up to ₹1,300.00 Cr | up to ₹400.84 Cr |
| OFS Issue Size | 4,71,34,935 shares | 85,25,520 shares |
| OFS Issue Size (Amount) | up to ₹2,550.00 Cr | up to ₹812.49 Cr |
| Issue Size Total | 7,11,64,509 shares | 1,27,31,605 shares |
| Issue Size Total (Amount) | up to ₹3,850.00 Cr | up to ₹1,213.33 Cr |
Chemplast Sanmar IPO opens on Aug 10, 2021, while Krsnaa Diagnostics IPO opens on Aug 04, 2021. The closing date of Chemplast Sanmar IPO and Krsnaa Diagnostics IPO is Aug 12, 2021, and Aug 06, 2021, respectively.
| Chemplast Sanmar IPO | Krsnaa Diagnostics IPO | |
|---|---|---|
| Anchor Bid Date | Aug 09, 2021 | Aug 03, 2021 |
| Issue Open | Aug 10, 2021 | Aug 04, 2021 |
| Issue Close | Aug 12, 2021 | Aug 06, 2021 |
| Basis Of Allotment (Tentative) | Aug 18, 2021 | Aug 11, 2021 |
| Initiation of Refunds (Tentative) | Aug 20, 2021 | Aug 12, 2021 |
| Credit of Share (Tentative) | Aug 23, 2021 | Aug 13, 2021 |
| Listing date (Tentative) | Aug 24, 2021 | Aug 16, 2021 |
| Anchor Lockin End date 1 | Sep 17, 2021 | Sep 10, 2021 |
| Anchor Lockin End date 2 | Nov 16, 2021 | Nov 09, 2021 |
Chemplast Sanmar IPO P/E ratio is , as compared to Krsnaa Diagnostics IPO P/E ratio of .
| Chemplast Sanmar IPO | Krsnaa Diagnostics IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 31.62 | ||||
| Promoter Shareholding (Post-Issue) | 54.99 | 27.38 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹8553.73 Cr. | ₹2996.23 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Chemplast Sanmar IPO Retail Individual Investors (RII) are offered 71,16,450 shares while in Krsnaa Diagnostics IPO retail investors are offered 71,16,450 shares. Qualified Institutional Buyers (QIB) are offered 2,13,49,354 shares in Chemplast Sanmar IPO and 37,52,625 shares in Krsnaa Diagnostics IPO.
| Chemplast Sanmar IPO | Krsnaa Diagnostics IPO | |
|---|---|---|
| Anchor Investor Reservation | 3,20,24,029 shares | 56,28,937 shares |
| Market Maker Reservation | ||
| QIB | 2,13,49,354 shares | 37,52,625 shares |
| NII | 1,06,74,676 shares | 18,76,312 shares |
| RII | 71,16,450 shares | 12,50,874 shares |
| Employee | 2,32,288 shares | |
| Others | ||
| Total | 7,11,64,509 shares | 1,27,41,036 shares |
Chemplast Sanmar IPO subscribed 2.17x in total, whereas Krsnaa Diagnostics IPO subscribed 64.38x.
| Chemplast Sanmar IPO | Krsnaa Diagnostics IPO | |
|---|---|---|
| QIB (times) | 2.70x | 49.83x |
| NII (times) | 1.03x | 116.30x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.29x | 41.95x |
| Employee (times) | 0.98x | |
| Other (times) | ||
| Total (times) | 2.17x | 64.38x |
